comparemela.com

Latest Breaking News On - Prometheus biosciences - Page 24 : comparemela.com

S&P 500 Gains and Losses Today: Pharma Stocks Fall After Pfizer, Merck Reports

The S&P 500 finished 0.3% lower on Tuesday, Aug. 1, 2023, as weaker-than-expected earnings from pharmaceutical companies weighed on the broader index.

Synaptics ioAdvanced micro devicesNorwegian cruise lineMolson coorsSynaptics incTraffic safety administrationCisco systemsArista networksMerck companyThat posted gainsMicro devicesSynaptics iotThat posted lossesNational highway traffic safety administrationPrometheus biosciences

Dow Jones Today: Caterpillar Earnings Lift Index

The price-weighted index rode gains from Caterpillar to move higher by 0.2%, or roughly 70 points, despite more than two-thirds of the index’s stocks falling.

Walgreens boots allianceMerck coDow jones industrial averageWith caterpillarCisco systemsAtlantic equitiesPrometheus biosciences

Merck (MRK) Q2 earnings report 2023

Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S.

Prometheus biosciencesWall streetNew jersey basedImago biosciencesHealth care industryBiotech and pharmaceuticalsDrug trialsCovid 19Breaking newsBreaking news earningsMerck amp co incJoe bidenPfizer incUnited statesBusiness news

Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal

Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S.

United statesMerck covidPrometheus biosciencesWall streetNew jersey basedImago biosciences

Merck Raises 2023 Sales Forecast as Cancer Drug Keytruda, Gardasil Vaccine Surge

Merck Raises 2023 Sales Forecast as Cancer Drug Keytruda, Gardasil Vaccine Surge
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Bloomberg merck coPrometheus biosciences incPrometheus biosciences

vimarsana © 2020. All Rights Reserved.